Mereo BioPharma Group plc announced that the merger with OncoMed Pharmaceuticals Inc. has been completed on April 23, 2019. The company also announced that Michael Wyzga and Deepa Pakianathan, Ph.D. on April 23, 2019 became non-executive directors of the company. Michael Wyzga served as a director of OncoMed from October 2013 until the closing of the Merger. Mr. Wyzga is currently the President of MSW Consulting Inc. Mr. Wyzga served as President and Chief Executive Officer and a member of the board of directors of Radius Health Inc. Prior to that, Mr. Wyzga served in various senior management positions at Genzyme Corporation, including as Chief Financial Officer from July 1999 until November 2011. Deepa Pakianathan served as a director of OncoMed from December 2008 until the closing of the Merger. Dr. Pakianathan has been a Managing Member at Delphi Ventures. Dr. Pakianathan serves on the boards of directors of Alder Biopharmaceuticals Inc., Karyopharm Therapeutics Inc., and Calithera Biosciences Inc. Dr. Pakianathan previously served on the boards of directors of Alexza Pharmaceuticals Inc., PTC Therapeutics Inc. and Relypsa Inc.